Aelius Biotech announced that it has raised £1.25 million in a round of funding on November 23, 2023. The transaction included participation from new investors North East Venture Fund, a fund co-managed by Mercia Fund Management Ltd. and Mercia Asset Management PLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.5 GBX | -0.59% | -4.29% | +10.93% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.93% | 181M | |
-6.44% | 88.47B | |
+15.32% | 84.55B | |
+12.36% | 26.01B | |
-6.65% | 17.28B | |
+6.74% | 14.28B | |
-16.11% | 13.16B | |
+16.00% | 9.52B | |
+26.11% | 8.75B | |
+27.22% | 7.13B |
- Stock Market
- Equities
- MERC Stock
- News Mercia Asset Management PLC
- Aelius Biotech announced that it has received £1.25 million in funding from Mercia Fund Management Ltd., Mercia Asset Management PLC